COVID-19 and telemedicine in haemophilia in a patient with severe haemophilia A and orthopaedic surgery
- PMID: 32516482
- PMCID: PMC7300968
- DOI: 10.1111/hae.14087
COVID-19 and telemedicine in haemophilia in a patient with severe haemophilia A and orthopaedic surgery
Keywords: COVID-19; haemophilia A; orthopedic; surgery; telemedicine.
Conflict of interest statement
Drs. Álvarez‐Román and Jiménez‐Yuste have participated as speakers, in advisory boards and sponsored symposia with Novo Nordisk, Takeda, Roche, Pfizer, Octapharma, Amgen, Novartis, CSL Behring and Sobi. Drs. De la Corte and
MTAR and VJY designed the work. MTAR wrote the letter. HdlC, ECRM, MMS and MIRP were responsible of patient's surgery, treatment and follow‐up. NVB, SGB, PA, TC, EG and EMM were responsible of data management. All authors analysed, revised critically and gave final approval of the manuscript.
Figures
References
-
- Organization WH . Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth. In: Organization WH , ed. Global Observatory for eHealth Series. Vol 2. WHO; 2010: 93.
-
- Lurie N, Carr BG. The role of telehealth in the medical response to disasters. JAMA Intern Med. 2018;178(6):745‐746. - PubMed
-
- Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid‐19. N Engl J Med. 2020;382(18):1679–1681. - PubMed
-
- https://www.wfh.org. Accessed April 26, 2020.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
